Biovica International AB (publ) (BIOVIC-B.ST)
BIOVIC-B.ST Stock Price Chart
Explore Biovica International AB (publ) interactive price chart. Choose custom timeframes to analyze BIOVIC-B.ST price movements and trends.
BIOVIC-B.ST Company Profile
Discover essential business fundamentals and corporate details for Biovica International AB (publ) (BIOVIC-B.ST) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
29 Mar 2017
Employees
26.00
Website
https://www.biovica.comCEO
Anders Rylander
Description
Biovica International AB (publ), a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in Sweden and internationally. It primarily focuses on breast cancer. The company develops DiviTum, a biomarker assay that measures the activity of the enzyme thymidine kinase-1 in blood serum or cell cultures. It serves cancer institutes, pharmaceutical companies, and collaborative groups. The company was incorporated in 2008 and is headquartered in Uppsala, Sweden.
BIOVIC-B.ST Financial Timeline
Browse a chronological timeline of Biovica International AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 17 Jun 2026
Upcoming earnings on 18 Mar 2026
Upcoming earnings on 18 Dec 2025
Upcoming earnings on 11 Sept 2025
EPS estimate is -kr 0.11.
Earnings released on 19 Jun 2025
EPS came in at -kr 0.21 surpassing the estimated -kr 0.31 by +32.26%, while revenue for the quarter reached kr 2.33M , missing expectations by -41.70%.
Earnings released on 13 Mar 2025
EPS came in at -kr 0.23 surpassing the estimated -kr 0.28 by +17.86%, while revenue for the quarter reached kr 2.26M , missing expectations by -36.31%.
Earnings released on 12 Dec 2024
EPS came in at -kr 0.23 surpassing the estimated -kr 0.24 by +4.17%, while revenue for the quarter reached kr 2.31M , missing expectations by -42.20%.
Earnings released on 12 Sept 2024
EPS came in at -kr 0.27 falling short of the estimated -kr 0.22 by -22.73%, while revenue for the quarter reached kr 1.71M , missing expectations by -14.30%.
Earnings released on 18 Jun 2024
EPS came in at -kr 0.47 falling short of the estimated -kr 0.39 by -20.51%, while revenue for the quarter reached kr 1.90M , missing expectations by -41.52%.
Earnings released on 14 Mar 2024
EPS came in at -kr 0.44 falling short of the estimated -kr 0.38 by -15.79%, while revenue for the quarter reached kr 1.08M , missing expectations by -88.06%.
Earnings released on 28 Nov 2023
EPS came in at -kr 0.53 falling short of the estimated -kr 0.28 by -89.29%, while revenue for the quarter reached kr 2.56M , missing expectations by -35.93%.
Stock split effective on 24 Nov 2023
Shares were split 1063 : 1000 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 6 Sept 2023
EPS came in at -kr 0.70 falling short of the estimated -kr 0.30 by -133.33%, while revenue for the quarter reached kr 1.75M , missing expectations by -12.30%.
Earnings released on 21 Jun 2023
EPS came in at -kr 0.81 falling short of the estimated -kr 0.45 by -80.00%, while revenue for the quarter reached kr 587.00K , missing expectations by -70.65%.
Earnings released on 16 Mar 2023
EPS came in at -kr 0.64 falling short of the estimated -kr 0.60 by -6.67%, while revenue for the quarter reached kr 1.29M , beating expectations by +31.71%.
Earnings released on 15 Dec 2022
EPS came in at -kr 0.81 , while revenue for the quarter reached kr 961.00K .
Earnings released on 31 Aug 2022
EPS came in at -kr 0.73 , while revenue for the quarter reached kr 545.00K , beating expectations by +9.00%.
Earnings released on 30 Jun 2022
EPS came in at -kr 0.62 falling short of the estimated -kr 0.37 by -68.89%, while revenue for the quarter reached kr 1.08M , missing expectations by -94.99%.
Earnings released on 15 Mar 2022
EPS came in at -kr 0.49 falling short of the estimated -kr 0.29 by -68.70%, while revenue for the quarter reached kr 314.00K , missing expectations by -98.20%.
Earnings released on 1 Dec 2021
EPS came in at -kr 0.50 falling short of the estimated -kr 0.20 by -150.00%, while revenue for the quarter reached kr 268.00K .
Earnings released on 31 Aug 2021
EPS came in at -kr 0.42 , while revenue for the quarter reached kr 381.00K .
Earnings released on 17 Jun 2021
EPS came in at -kr 0.42 , while revenue for the quarter reached kr 318.00K .
Earnings released on 18 Mar 2021
EPS came in at -kr 0.37 , while revenue for the quarter reached kr 1.38M .
Earnings released on 3 Dec 2020
EPS came in at -kr 0.28 , while revenue for the quarter reached kr 44.00K .
BIOVIC-B.ST Stock Performance
Access detailed BIOVIC-B.ST performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.